Product
SON-DP
1 clinical trial
5 indications
Indication
Solid TumorIndication
Breast CancerIndication
Pancreatic CancerIndication
Ovarian CancerIndication
Colorectal CancerClinical trial
A First-in-Human (FIH), Open-Label, Phase Ia/Ib Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SON-DP in Participants With Relapsed/Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2025-09-01